about
Rapid regulation of depression-related behaviours by control of midbrain dopamine neuronsβ-catenin mediates stress resilience through Dicer1/microRNA regulationSelf-administration of ethanol, cocaine, or nicotine does not decrease the soma size of ventral tegmental area dopamine neuronsAKT signaling within the ventral tegmental area regulates cellular and behavioral responses to stressful stimuli.Nucleus accumbens dopamine mediates amphetamine-induced impairment of social bonding in a monogamous rodent species.Enduring deficits in brain reward function after chronic social defeat in rats: susceptibility, resilience, and antidepressant responseBDNF is a negative modulator of morphine action.Locus-specific epigenetic remodeling controls addiction- and depression-related behaviors.Nuclear factor kappa B signaling regulates neuronal morphology and cocaine reward.Epigenetic basis of opiate suppression of Bdnf gene expression in the ventral tegmental areaCholine transporter gene variation is associated with attention-deficit hyperactivity disorder.Role for mTOR signaling and neuronal activity in morphine-induced adaptations in ventral tegmental area dopamine neuronsDishevelled-2 regulates cocaine-induced structural plasticity and Rac1 activity in the nucleus accumbens.Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation.Fluoxetine exposure during adolescence increases preference for cocaine in adulthoodRac1 is essential in cocaine-induced structural plasticity of nucleus accumbens neuronsBehavioral and structural responses to chronic cocaine require a feedforward loop involving ΔFosB and calcium/calmodulin-dependent protein kinase II in the nucleus accumbens shell.Calcium-sensitive adenylyl cyclases in depression and anxiety: behavioral and biochemical consequences of isoform targetingPrefrontal cortical circuit for depression- and anxiety-related behaviors mediated by cholecystokinin: role of ΔFosB.Fluoxetine epigenetically alters the CaMKIIα promoter in nucleus accumbens to regulate ΔFosB binding and antidepressant effects.Stress and CRF gate neural activation of BDNF in the mesolimbic reward pathway.Deletion of Rictor in catecholaminergic neurons alters locomotor activity and ingestive behavior.Reward Circuitry in Addiction.Expression studies of naturally occurring human dopamine transporter variants identifies a novel state of transporter inactivation associated with Val382Ala.Experience-Dependent Induction of Hippocampal ΔFosB Controls Learning.Single nucleotide polymorphisms in the human norepinephrine transporter gene affect expression, trafficking, antidepressant interaction, and protein kinase C regulation.Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder.Determination of circuit-specific morphological adaptations in ventral tegmental area dopamine neurons by chronic morphine
P50
Q24630584-A47286F4-9432-42C1-B845-D26FADFD749DQ28251285-6EF3E2A5-C1C5-498D-912D-355C5DC5ACDBQ28538136-56A45AC6-A0F2-450F-88F5-52D64464E539Q30490140-3108669A-8140-4CF3-9746-72B08BFEA82EQ33666834-5BD485FB-0B91-4A7C-86C7-8E3EAFFBFA03Q33983943-6216BD85-4413-4D18-B771-5D73931BE056Q34304358-6A3B42A2-DE20-438F-9F9A-9DB9C46A5F9BQ34560157-4D2CAEC4-6C91-4B79-8E04-F064EADC223EQ34964519-78DE5616-C73A-496B-917B-E3CA3958FF06Q35122229-7FE81090-D3B7-4F30-AF33-4490911DF60DQ35187232-FBF3C15D-707B-4A9B-AEFF-578B22495288Q35634446-6F63BEB7-F23F-453D-A1D8-E79119D58498Q35685372-294144D8-49F5-44F5-8ECA-02864BD4701DQ35927547-89C35AD7-B832-4BE1-B539-2B59C39BCFA7Q36139355-0F0A9F63-B243-434A-8514-1BFD5E267C2DQ36590613-7D98FA5F-A3B1-49D9-B480-5A530335C03DQ36856397-D022315C-EF3E-40F8-8C63-AE8BFEE0A0F4Q36966260-8604198B-075B-4019-A5EC-ED1E4C9E9AE8Q37633608-5A497693-2493-480C-887C-743F6AB71742Q37642433-9CDC6E7A-0A1D-4D0F-907A-114919E9B7D3Q38725380-069FCC62-2AE3-42C6-A1EC-FAE19D68CAE8Q38975787-85B53D91-CED7-4D0F-B200-4D95045EF091Q39190673-75EA72A9-CECB-41E8-955A-163B85A48D08Q40364207-88419025-E13D-4383-91D2-8981802DC4F8Q41250723-0A20DD88-5BB4-4F52-968D-D3D559E34708Q46491269-1975EBDF-FBB0-431C-81A9-BEDD8936F173Q46649719-F798F741-8D12-4CBB-8CB6-03314789BB3BQ61797491-9D1D7AC5-47DE-417F-A9A7-53E5B086C059
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Michelle S Mazei-Robison
@ast
Michelle S Mazei-Robison
@en
Michelle S Mazei-Robison
@es
Michelle S Mazei-Robison
@nl
Michelle S Mazei-Robison
@sl
type
label
Michelle S Mazei-Robison
@ast
Michelle S Mazei-Robison
@en
Michelle S Mazei-Robison
@es
Michelle S Mazei-Robison
@nl
Michelle S Mazei-Robison
@sl
prefLabel
Michelle S Mazei-Robison
@ast
Michelle S Mazei-Robison
@en
Michelle S Mazei-Robison
@es
Michelle S Mazei-Robison
@nl
Michelle S Mazei-Robison
@sl
P214
P244
P1053
I-4304-2017
P106
P21
P214
P244
no2006115716
P31
P3829
P496
0000-0002-2372-1420
P735
P7859
lccn-no2006115716